Austin Freedman has extensive and varied experience in Industrial Pharmacy, Pharmaceutics, Pharmaceutical R&D and Technology Transfer project leadership in the UK and Canada through Glaxo, GlaxoWellcome, GlaxoSmithKline, Patheon and Apotex. Austin’s accomplishments in technical project leadership are complemented by his skills in business management with P&L accountability, client relationship management and organizational & operational development.
Austin began his career in the pharmaceutical industry by joining the Pharmaceutical Research Department of Glaxo Group Research, UK. During the next 15 years, Austin gained in-depth knowledge and practical understanding in developing a wide range of pharmaceutical solid and liquid (including parenteral) products, spanning the entire drug development process from pre-clinical development to scale up and transfer to commercial production.
After joining Patheon in Canada in 2002, Austin had a variety of senior roles that combined his technical knowledge and business leadership to enable multidisciplinary pharmaceutical development units to meet the requirements of diverse portfolios of clients’ projects, which included formulation and manufacturing process development to support regulatory submissions, clinical programs and technology transfers.
In 2011, Austin joined Apotex as Director, Technical Operations at the site in Etobicoke, Ontario, where he facilitated operational excellence and new product launches in the fast-paced generic pharmaceutical environment. While at Apotex, Austin developed and implemented technology transfer process improvements to enable manufacturing processes for a wide variety of products to be transferred robustly between sites in Canada, Europe and India.